Gestala Raises $84M for Brain Interfaces
Chinese BCI platform Gestala raised about $84M, adding to global investor momentum around brain-computer interfaces.
Brain-computer interfaces are becoming a more global deeptech funding category.
What happened
Chinese brain-computer interface platform Gestala raised about $84M from investors including HSG, Lens Technology, Sinovation Ventures, C Capital, Dalton Venture, Seas Capital, Tsing Song Capital and Gobi Partners.
The company is part of a broader wave of startups building hardware and software systems that can interpret neural signals for medical or human-computer interaction use cases.
Why it matters
This is a relevant healthtech and deeptech signal. Brain-computer interfaces combine neuroscience, specialised hardware, signal processing, AI and long clinical or regulatory pathways.
Large rounds in this category show investor appetite for frontier healthcare technologies even when commercialisation timelines are long.
The bigger picture
BCI is still early, but the category is no longer confined to a handful of US companies.
Funding for companies like Gestala suggests a more distributed global race in neural interfaces, where technical progress, clinical evidence and regulatory access will all shape who can turn research into durable products.